Compare Alcon AG (ALC) vs Sezzle Inc (SEZL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Sezzle Inc — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while Sezzle Inc trades at $167.32 (market cap $5.97B). The key difference: Alcon AG is far larger — about 5.5× Sezzle Inc's market cap, and Alcon AG pays a 0.54% dividend while Sezzle Inc pays none. Which is the better fit depends on your goals.
| ALC | SEZL | |
|---|---|---|
Market Cap | $32.69B | $5.97B |
Sector | Health | Technology |
52-Week High | $92.22 | $183.24 |
52-Week Low | $62.02 | $50.97 |
Enterprise Value | $36.28B | $6.00B |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Sezzle (SEZL) trades at $179.05, down 2.29% today, but maintains a strong bullish technical trend with moving averages supporting further upside. Fundamentally, the company exhibits robust profitability with a 30.83% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights product expansion and strong Q1 2026 results, driving positive sentiment.
The outlook remains positive given accelerating revenue growth and raised guidance, though risks include potential securities litigation and high valuation multiples. Analysts are predominantly bullish with a consensus price target of $146.40, suggesting caution near-term, but operational momentum supports long-term growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Sezzle Inc
Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →
